April 21, 2026 a 07:43 pm
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. operates within the healthcare sector, focusing on manufacturing containment and delivery systems for injectable drugs. This analysis provides an overview of the company's fundamental ratings and outlook. Currently, the stock displays moderate growth potential, though it is essential to consider industry trends and economic shifts impacting the company's performance.
Fundamental Rating
West Pharmaceutical Services, Inc. has a solid foundation with fundamental scores indicating a stable position in the market. It holds potential in areas such as return on assets and equity, though debt obligations and valuation ratios reflect cautious investor optimism.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The historical ratings provide an insight into the company's evolving financial health. The following data compares current scores against previous evaluations, offering a benchmark for performance improvement.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-21 | 3 | 3 | 4 | 5 | 2 | 2 | 1 |
| Previous (Placeholder Date) | 0 | 3 | 4 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Analyst price targets suggest a potential growth trajectory with a consensus aiming toward a future price increase. Current analytical projections provide a range from conservative to optimistic forecasts, beneficial for long-term strategic planning.
| High | Low | Median | Consensus |
|---|---|---|---|
| $340 | $265 | $305 | $303.33 |
Analyst Sentiment
Analyst sentiment toward the stock remains predominantly positive, with a significant number of buy ratings suggesting confidence in the company's market potential.
| Recommendation | Number | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. presents a stable investment with room for growth, as indicated by fundamental and analytical metrics. The firm is well-positioned within the healthcare industry, which continues to offer expansion opportunities, despite economic fluctuations. However, investors should remain cautious about potential risks associated with debt levels and market competition. Overall, the company's strong market presence and innovative product offerings provide a robust platform for future gains.